GlassScriptPhysician profile
Hyun Ji
NPI 1689179509
$8,367.69
in general payments reported to CMS, 2019-2025
6 companies · $2,858 in 2025
The $2,858 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,828 · 2024: $3,682 · 2025: $2,858.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,392 · Food and Beverage: $2,276 · Consulting Fee: $900 · Grant: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,391.77 |
| Food and Beverage | $2,275.92 |
| Consulting Fee | $900.00 |
| Grant | $800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,203.28 | 2024-2025 | Axios, Exalt Model D, Overstitch Endoscopic Suturing System |
| Neptune Medical INC. | $900.00 | 2023 | |
| Cook Incorporated | $800.00 | 2023 | |
| Fujifilm Healthcare Americas Corporation | $219.85 | 2025 | |
| Abbvie INC. | $127.84 | 2023 | |
| Micro-Tech Endoscopy USA, INC. | $116.72 | 2025 | Eyemax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hyun Ji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.